Molecular Partners AG — Investor Relations & Filings
Molecular Partners AG is a clinical-stage biopharmaceutical company pioneering the design and development of a novel class of protein therapeutics known as DARPin® therapies. DARPins (Designed Ankyrin Repeat Proteins) are a proprietary class of small, custom-built proteins engineered to bind to specific disease targets with high potency and specificity. The company leverages its platform to create multi-specific drug candidates capable of engaging multiple targets or pathways simultaneously. The development pipeline is primarily focused on advancing innovative treatments in oncology, with clinical programs targeting serious diseases such as acute myeloid leukemia (AML). The company's approach aims to address complex medical challenges by utilizing the unique properties of its engineered protein platform.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| F-1/A | 2021-05-04 | English | |
| Regulatory Filings 2021 | 2021-04-22 | English | |
| F-1 | 2021-04-22 | English | |
| Regulatory Filings 2021 | 2021-04-12 | English | |
| Regulatory Filings 2021 | 2021-03-13 | English | |
| Molecular Partners AG: Molecular Partners Successfully Completes the Launch of a Private Placement of 5,528,089 Shares by way of an Accelerated Bookbuilding | 2020-07-07 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
5 filings
| |||||
| 13122320 | F-1/A | 2021-05-04 | English | ||
| 13122321 | Regulatory Filings 2021 | 2021-04-22 | English | ||
| 13122322 | F-1 | 2021-04-22 | English | ||
| 13122323 | Regulatory Filings 2021 | 2021-04-12 | English | ||
| 13122324 | Regulatory Filings 2021 | 2021-03-13 | English | ||
|
2020
2 filings
| |||||
| 1678301 | Molecular Partners AG: Molecular Partners Successfully Completes the Launch of a Private Placement of 5,528,089 Shares by way of an Accelerated Bookbuilding | 2020-07-07 | English | ||
| 1690673 | Molecular Partners Initiates Anti-COVID-19 Therapeutic Program Leveraging Multi-Target Binding of DARPin(R) Proteins to Neutralize SARS-CoV-2 Virus | 2020-04-19 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Molecular Partners AG, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Molecular Partners AG via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/934/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=934 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=934 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=934 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 934}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Molecular Partners AG (id: 934)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.